Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle

NCT03079401 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Hypoplastic Left Heart Syndrome
Atrioventricular Canal

Interventions

BIOLOGICAL: MPC; rexlemestrocel-L

Sponsor

Boston Children's Hospital